lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1

被引:1
|
作者
Gu, Jie [1 ]
Dai, Bo [1 ]
Shi, Xuchao [1 ]
He, Zhennian [1 ]
Xu, Yuanlin [1 ]
Meng, Xiangqian [2 ]
Zhu, Junlan [3 ]
机构
[1] Beilun Peoples Hosp, Dept Orthopaed Surg, Ningbo, Zhejiang, Peoples R China
[2] Beilun Peoples Hosp, Dept Stomatol, Ningbo, Zhejiang, Peoples R China
[3] Beilun Peoples Hosp, Precis Med Lab, Ningbo, Zhejiang, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 17期
关键词
osteosarcoma; long non-coding RNA; human leukocyte antigen complex group 11; p27; Kip1; miR-942-5p; IGF2BP2; TUMORIGENESIS; EXPRESSION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osteosarcoma (OS) is a common malignant bone cancer threatening children and young adults. Emerging evidence indicates that long non-coding RNAs (lncRNAs) play crucial roles in the progression of OS. Herein, we want to clarify the roles of lncRNA human leukocyte antigen complex group 11 (HCG11) in OS. Our data revealed that HCG11 expression is decreased in OS, which is a result of transcriptional repression of YY1. Low HCG11 level is closely associated with larger tumor size and shorter overall survival of OS patients. HCG11 negatively regulates cell proliferation, cell cycle, DNA replication in vitro and tumor growth in vivo. HCG11 can raise p27 Kip1 expression via binding to miR-942-5p and IGF2BP2, and p27 Kip1 acts as a key effector for HCG11 exerting biological functions. In conclusion, HCG11 is downregulated in OS, and restrains OS growth both in vitro and in vivo by raising p27 Kip1 expression via binding to miR-942-5p and IGF2BP2.
引用
收藏
页码:21743 / 21757
页数:15
相关论文
共 50 条
  • [1] p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma
    Arthur W. Currier
    E. A. Kolb
    Richard G. Gorlick
    Michael E. Roth
    Vidya Gopalakrishnan
    Valerie B. Sampson
    Scientific Reports, 9
  • [2] p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma
    Currier, Arthur W.
    Kolb, E. A.
    Gorlick, Richard G.
    Roth, Michael E.
    Gopalakrishnan, Vidya
    Sampson, Valerie B.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] p27/kip1 expression in human astrocytic gliomas
    Piva, R
    Cavalla, P
    Bortolotto, S
    Cordera, S
    Richiardi, P
    Schiffer, D
    NEUROSCIENCE LETTERS, 1997, 234 (2-3) : 127 - 130
  • [4] Deregulated expression of p27(Kip1) in human breast cancers
    Sgambato, A
    Zhang, YJ
    Arber, N
    Hibshoosh, H
    Doki, Y
    Ciaparrone, M
    Santella, RM
    Cittadini, A
    Weinstein, IB
    CLINICAL CANCER RESEARCH, 1997, 3 (10) : 1879 - 1887
  • [5] Expression of p27(KIP1) and cell proliferation in human retina and retinoblastoma
    Kase, S
    Yoshida, K
    Ohgami, K
    Shiratori, K
    Harada, T
    Ohno, S
    ANTICANCER RESEARCH, 2005, 25 (6B) : 3843 - 3846
  • [6] Molecular cloning and characterization of the human p27(Kip1) gene promoter
    Minami, S
    OhtaniFujita, N
    Igata, E
    Tamaki, T
    Sakai, T
    FEBS LETTERS, 1997, 411 (01) : 1 - 6
  • [7] Phosphorylation of p27(KIP1) in the developing retina and retinoblastoma
    Kase, S
    Yoshida, K
    Nakayama, KI
    Nakayama, K
    Ikeda, H
    Harada, T
    Harada, C
    Ohgami, K
    Shiratori, K
    Ohno, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (02) : 257 - 262
  • [8] p27/Kip1 mutation found in breast cancer
    Spirin, KS
    Simpson, JF
    Takeuchi, S
    Kawamata, N
    Miller, CW
    Koeffler, HP
    CANCER RESEARCH, 1996, 56 (10) : 2400 - 2404
  • [9] Cyclin-dependent kinase inhibitor p27(KIP1) in lymphoid tissue - p27(KIP1) expression is inversely proportional to the proliferative index
    SanchezBeato, M
    Saez, AI
    MartinezMontero, JC
    Mateo, MS
    SanchezVerde, L
    Villuendas, R
    Troncone, G
    Piris, MA
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (01): : 151 - 160
  • [10] P27(Kip1)的研究进展
    卢瑞南
    国外医学(分子生物学分册), 2003, (03) : 171 - 174